Evidence map›Paper›PMID 30813264›Full record

ReviewInternational journal of molecular sciences2019

Resveratrol as a Multifunctional Topical Hypopigmenting Agent.

Jung-Im Na, Jung-Won Shin, Hye-Ryung Choi, Soon-Hyo Kwon, Kyung-Chan Park

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Ultraviolet B-induced oxidative damage in human skin keratinocytes is alleviated byRedox report : communications in free radical research · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. An Update on New and Existing Treatments for the Management of Melasma.American journal of clinical dermatology · 2024
    Review
  11. Article
  12. Molecules (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update.Journal of clinical and translational hepatology · 2021
    Review
  18. The Oxidation of Equol by Tyrosinase Produces a Unique Di-International journal of molecular sciences · 2021
    Article
  19. Review
  20. The Application of Skin Care Product in Melasma Treatment.Clinical, cosmetic and investigational dermatology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jung-Im NaDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea. vividna@gmail.com.ORCID 0000-0002-5717-2490
Jung-Won ShinDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea. spellbound00@hanmail.net.
Hye-Ryung ChoiDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea. hrchoi73@snu.ac.kr.
Soon-Hyo KwonDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea. soonhyo17@hanmail.net.ORCID 0000-0002-7295-5725
Kyung-Chan ParkDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea. gcpark@snu.ac.kr.
Seoul National University Bundang Hospital · KR

Funding

Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea HN14C0094
6 · The paper itself

Abstract

Melanin is produced in melanocytes and stored in melanosomes, after which it is transferred to keratinocytes and, thus, determines skin color. Despite its beneficial sun-protective effects, abnormal accumulation of melanin results in esthetic problems. A range of topical hypopigmenting agents have been evaluated for their use in the treatment of pigmentary disorders with varying degrees of success. Hydroquinone (HQ), which competes with tyrosine, is the main ingredient in topical pharmacological agents. However, frequent occurrence of adverse reactions is an important factor that limits its use. Thus, efforts to discover effective topical hypopigmenting agents with less adverse effects continue. Here, we describe the potential of resveratrol to function as an effective hypopigmenting agent based on its mechanism of action. Resveratrol is not only a direct tyrosinase inhibitor but an indirect inhibitor as well. Additionally, it can affect keratinocytes, which regulate the function of melanocytes. Resveratrol regulates the inflammatory process of keratinocytes and protects them from oxidative damage. In this way, it prevents keratinocyte-induced melanocyte stimulation. Furthermore, it has a rescuing effect on the stemness of interfollicular epidermal cells that can repair signs of photoaging in the melasma, a typical pigmentary skin disorder. Overall, resveratrol is a promising potent hypopigmenting agent.

Indexed as

Administration, TopicalAnimalsHumansHypopigmentationKeratinocytesMelanocytesMelanomaResveratrolResveratrolantioxidanthypopigmenting agentmelanogenesisresveratroltyrosinase inhibitor

Identifiers

PMID30813264
PMCPMC6412432
OpenAlexW2916970561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.